Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
gptkb:public_company |
| gptkbp:collaboratedWith |
gptkb:BioNTech
|
| gptkbp:developedBy |
gptkb:COVID-19_vaccine_(BNT162b2,_with_BioNTech)
|
| gptkbp:foundedIn |
1994
|
| gptkbp:headquartersLocation |
gptkb:Shanghai,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fosun Pharma
|
| gptkbp:industry |
healthcare
pharmaceuticals |
| gptkbp:keyPerson |
gptkb:Chen_Qiyu
gptkb:Wu_Yifang |
| gptkbp:numberOfEmployees |
over 20,000
|
| gptkbp:parentCompany |
gptkb:Fosun_International
|
| gptkbp:products |
pharmaceuticals
medical devices healthcare services diagnostic products |
| gptkbp:stockExchange |
gptkb:Hong_Kong_Stock_Exchange
gptkb:Shanghai_Stock_Exchange |
| gptkbp:stockSymbol |
02196
600196 |
| gptkbp:subsidiary |
gptkb:Gland_Pharma
gptkb:Shanghai_Fosun_Pharmaceutical_Development_Co.,_Ltd. |
| gptkbp:website |
https://www.fosunpharma.com/en/
|
| gptkbp:bfsParent |
gptkb:BioNTech
|
| gptkbp:bfsLayer |
5
|